Cargando…
Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic Cardiomyopathy
Background: Carriers of pathogenic DNA variants (G+) causing hypertrophic cardiomyopathy (HCM) can be identified by genetic testing. Several abnormalities have been brought forth as pre-clinical expressions of HCM, some of which can be identified by cardiovascular magnetic resonance (CMR). In this s...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484536/ https://www.ncbi.nlm.nih.gov/pubmed/34604355 http://dx.doi.org/10.3389/fcvm.2021.727405 |
_version_ | 1784577338637287424 |
---|---|
author | van der Velde, Nikki Huurman, Roy Hassing, H. Carlijne Budde, Ricardo P. J. van Slegtenhorst, Marjon A. Verhagen, Judith M. A. Schinkel, Arend F. L. Michels, Michelle Hirsch, Alexander |
author_facet | van der Velde, Nikki Huurman, Roy Hassing, H. Carlijne Budde, Ricardo P. J. van Slegtenhorst, Marjon A. Verhagen, Judith M. A. Schinkel, Arend F. L. Michels, Michelle Hirsch, Alexander |
author_sort | van der Velde, Nikki |
collection | PubMed |
description | Background: Carriers of pathogenic DNA variants (G+) causing hypertrophic cardiomyopathy (HCM) can be identified by genetic testing. Several abnormalities have been brought forth as pre-clinical expressions of HCM, some of which can be identified by cardiovascular magnetic resonance (CMR). In this study, we assessed morphological differences between G+/left ventricular hypertrophy-negative (LVH-) subjects and healthy controls and examined whether CMR-derived variables are useful for the prediction of sarcomere gene variants. Methods: We studied 57 G+ subjects with a maximal wall thickness (MWT) < 13 mm, and compared them to 40 healthy controls matched for age and sex on a group level. Subjects underwent CMR including morphological, volumetric and function assessment. Logistic regression analysis was performed for the determination of predictive CMR characteristics, by which a scoring system for G+ status was constructed. Results: G+/LVH- subjects were subject to alterations in the myocardial architecture, resulting in a thinner posterior wall thickness (PWT), higher interventricular septal wall/PWT ratio and MWT/PWT ratio. Prominent hook-shaped configurations of the anterobasal segment were only observed in this group. A model consisting of the anterobasal hook, multiple myocardial crypts, right ventricular/left ventricular ratio, MWT/PWT ratio, and MWT/left ventricular mass ratio predicted G+ status with an area under the curve of 0.92 [0.87–0.97]. A score of ≥3 was present only in G+ subjects, identifying 56% of the G+/LVH- population. Conclusion: A score system incorporating CMR-derived variables correctly identified 56% of G+ subjects. Our results provide further insights into the wide phenotypic spectrum of G+/LVH- subjects and demonstrate the utility of several novel morphological features. If genetic testing for some reason cannot be performed, CMR and our purposed score system can be used to detect possible G+ carriers and to aid planning of the control intervals. |
format | Online Article Text |
id | pubmed-8484536 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84845362021-10-02 Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic Cardiomyopathy van der Velde, Nikki Huurman, Roy Hassing, H. Carlijne Budde, Ricardo P. J. van Slegtenhorst, Marjon A. Verhagen, Judith M. A. Schinkel, Arend F. L. Michels, Michelle Hirsch, Alexander Front Cardiovasc Med Cardiovascular Medicine Background: Carriers of pathogenic DNA variants (G+) causing hypertrophic cardiomyopathy (HCM) can be identified by genetic testing. Several abnormalities have been brought forth as pre-clinical expressions of HCM, some of which can be identified by cardiovascular magnetic resonance (CMR). In this study, we assessed morphological differences between G+/left ventricular hypertrophy-negative (LVH-) subjects and healthy controls and examined whether CMR-derived variables are useful for the prediction of sarcomere gene variants. Methods: We studied 57 G+ subjects with a maximal wall thickness (MWT) < 13 mm, and compared them to 40 healthy controls matched for age and sex on a group level. Subjects underwent CMR including morphological, volumetric and function assessment. Logistic regression analysis was performed for the determination of predictive CMR characteristics, by which a scoring system for G+ status was constructed. Results: G+/LVH- subjects were subject to alterations in the myocardial architecture, resulting in a thinner posterior wall thickness (PWT), higher interventricular septal wall/PWT ratio and MWT/PWT ratio. Prominent hook-shaped configurations of the anterobasal segment were only observed in this group. A model consisting of the anterobasal hook, multiple myocardial crypts, right ventricular/left ventricular ratio, MWT/PWT ratio, and MWT/left ventricular mass ratio predicted G+ status with an area under the curve of 0.92 [0.87–0.97]. A score of ≥3 was present only in G+ subjects, identifying 56% of the G+/LVH- population. Conclusion: A score system incorporating CMR-derived variables correctly identified 56% of G+ subjects. Our results provide further insights into the wide phenotypic spectrum of G+/LVH- subjects and demonstrate the utility of several novel morphological features. If genetic testing for some reason cannot be performed, CMR and our purposed score system can be used to detect possible G+ carriers and to aid planning of the control intervals. Frontiers Media S.A. 2021-09-17 /pmc/articles/PMC8484536/ /pubmed/34604355 http://dx.doi.org/10.3389/fcvm.2021.727405 Text en Copyright © 2021 van der Velde, Huurman, Hassing, Budde, van Slegtenhorst, Verhagen, Schinkel, Michels and Hirsch. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine van der Velde, Nikki Huurman, Roy Hassing, H. Carlijne Budde, Ricardo P. J. van Slegtenhorst, Marjon A. Verhagen, Judith M. A. Schinkel, Arend F. L. Michels, Michelle Hirsch, Alexander Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic Cardiomyopathy |
title | Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic Cardiomyopathy |
title_full | Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic Cardiomyopathy |
title_fullStr | Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic Cardiomyopathy |
title_full_unstemmed | Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic Cardiomyopathy |
title_short | Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic Cardiomyopathy |
title_sort | novel morphological features on cmr for the prediction of pathogenic sarcomere gene variants in subjects without hypertrophic cardiomyopathy |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484536/ https://www.ncbi.nlm.nih.gov/pubmed/34604355 http://dx.doi.org/10.3389/fcvm.2021.727405 |
work_keys_str_mv | AT vanderveldenikki novelmorphologicalfeaturesoncmrforthepredictionofpathogenicsarcomeregenevariantsinsubjectswithouthypertrophiccardiomyopathy AT huurmanroy novelmorphologicalfeaturesoncmrforthepredictionofpathogenicsarcomeregenevariantsinsubjectswithouthypertrophiccardiomyopathy AT hassinghcarlijne novelmorphologicalfeaturesoncmrforthepredictionofpathogenicsarcomeregenevariantsinsubjectswithouthypertrophiccardiomyopathy AT buddericardopj novelmorphologicalfeaturesoncmrforthepredictionofpathogenicsarcomeregenevariantsinsubjectswithouthypertrophiccardiomyopathy AT vanslegtenhorstmarjona novelmorphologicalfeaturesoncmrforthepredictionofpathogenicsarcomeregenevariantsinsubjectswithouthypertrophiccardiomyopathy AT verhagenjudithma novelmorphologicalfeaturesoncmrforthepredictionofpathogenicsarcomeregenevariantsinsubjectswithouthypertrophiccardiomyopathy AT schinkelarendfl novelmorphologicalfeaturesoncmrforthepredictionofpathogenicsarcomeregenevariantsinsubjectswithouthypertrophiccardiomyopathy AT michelsmichelle novelmorphologicalfeaturesoncmrforthepredictionofpathogenicsarcomeregenevariantsinsubjectswithouthypertrophiccardiomyopathy AT hirschalexander novelmorphologicalfeaturesoncmrforthepredictionofpathogenicsarcomeregenevariantsinsubjectswithouthypertrophiccardiomyopathy |